Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study
Yun Yong Seo, Yong Kyun Cho, Ji-Cheol Bae, et al.
Endocrinology and Metabolism (2013) Vol. 28, Iss. 1, pp. 41-41
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Jukić, et al.
World Journal of Gastroenterology (2014) Vol. 20, Iss. 48, pp. 18070-18070
Open Access | Times Cited: 299
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
Yamei Duan, Xiongfeng Pan, Jiayou Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 217
Cellular Mechanisms of Liver Fibrosis
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 178
The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
Ilias D. Vachliotis, Stergios A. Pοlyzos
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 191-206
Open Access | Times Cited: 41
The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
Samukelisiwe Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110785-110785
Open Access | Times Cited: 114
An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function.
Ju Hee Lee, Yea Eun Kang, Joon Young Chang, et al.
PubMed (2016) Vol. 8, Iss. 11, pp. 4750-4763
Closed Access | Times Cited: 97
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease
Flavia Agata Cimini, Ilaria Barchetta, Simone Carotti, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 19, pp. 3407-3407
Open Access | Times Cited: 90
Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
Eun‐Jung Rhee
Endocrinology and Metabolism (2019) Vol. 34, Iss. 3, pp. 226-226
Open Access | Times Cited: 88
Redox Regulation by Protein S-Glutathionylation: From Molecular Mechanisms to Implications in Health and Disease
Aysenur Musaogullari, Yuh-Cherng Chai
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8113-8113
Open Access | Times Cited: 86
Antitumor Mechanisms of Lycium barbarum Fruit: An Overview of In Vitro and In Vivo Potential
Maria Rosaria Miranda, Vincenzo Vestuto, Giuseppina Amodio, et al.
Life (2024) Vol. 14, Iss. 3, pp. 420-420
Open Access | Times Cited: 14
Berberine prevents NAFLD and HCC by modulating metabolic disorders
Xinyue Lin, Jilei Zhang, Yajun Chu, et al.
Pharmacology & Therapeutics (2024) Vol. 254, pp. 108593-108593
Closed Access | Times Cited: 13
Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
Feliciano Chanana Paquissi
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 74
Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation
Victoria L. Slaughter, John W. Rumsey, Rachel Boone, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 48
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
Inha Jung, Dae-Jeong Koo, Won‐Young Lee
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 3, pp. 327-339
Open Access | Times Cited: 6
Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, et al.
Antioxidants (2019) Vol. 8, Iss. 8, pp. 276-276
Open Access | Times Cited: 54
A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective study
Jing Xiong, Xia Chen, Zhijing Zhao, et al.
Experimental and Therapeutic Medicine (2022) Vol. 24, Iss. 3
Open Access | Times Cited: 26
Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions
Hong-Ju Sun, Bo Jiao, Yan Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 14, pp. 1968-1981
Open Access | Times Cited: 5
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, et al.
BMC Gastroenterology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 36
Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease
Mengyao Zhao, Shumin Chen, Xiaoguo Ji, et al.
Pharmacological Research (2021) Vol. 166, pp. 105517-105517
Closed Access | Times Cited: 32
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 27
Inflammatory cytokines, soluble interleukin-6 receptors, and fragmented cytokeratin-18 as indicators of non-alcoholic steatohepatitis
A. A. Shipovskaya, О. П. Дуданова, И. В. Курбатова
Terapevticheskii arkhiv (2025) Vol. 97, Iss. 2, pp. 115-120
Open Access
A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease
Abbas Ali Sangouni, Saeid Ghavamzadeh, Atena Jamalzehi
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2019) Vol. 13, Iss. 3, pp. 2260-2265
Closed Access | Times Cited: 30
Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation
Do Hyeon Pyun, Tae Jin Kim, Seung Yeon Park, et al.
Molecular and Cellular Endocrinology (2021) Vol. 538, pp. 111464-111464
Closed Access | Times Cited: 23
Association between inflammatory markers and non-alcoholic fatty liver disease in obese children
Yamei Duan, Jiayou Luo, Xiongfeng Pan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 18
The biological clock enhancer nobiletin ameliorates steatosis in genetically obese mice by restoring aberrant hepatic circadian rhythm
Sebastian Larion, Caleb A. Padgett, Joshua T. Butcher, et al.
AJP Gastrointestinal and Liver Physiology (2022) Vol. 323, Iss. 4, pp. G387-G400
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top